Monday, April 25th @ 7-8pm EST
The First of Three Lectures in our 43rd Annual Frank L LeFever Spring Conference
Our 3 Part Virtual Conference will focus on Covid-19
Douglas Whiteside, PhD, ABPP/CN
Neuropsychological Outcome in Long COVID-19 Patients
Abstract: COVID-19 is perhaps the most serious public health crisis in decades due to the widespread impact on society and individuals. This presentation will examine the common issues neuropsychologists face when evaluating adult patients with long-term COVID-19 symptoms and complaints. The research literature is only now starting to emerge, and there is a considerable amount still unknown about the long-term outcome of COVID-19. However, initial empirical data and case presentation will illustrate common issues seen in adults with long-term COVID-19 complaints as well as limitations to that data related to health disparities.
Dr. Whiteside is a board certified clinical neuropsychologist and Professor of Rehabilitation Medicine at the University of Minnesota. He is also the Director of Training for the Neuropsychology Division and is currently working on collaborative research examining cognitive sequelae of severe COVID-19 infection. Dr. Whiteside earned his PhD from the University of Nebraska after completing internship at the Ann Arbor VA Medical Center, and he completed postdoctoral training in neuropsychology at the Albuquerque VA Medical Center. Dr. Whiteside is a native Midwesterner, who serves as the Program Director for the Clinical Neuropsychology Residency program. He is actively involved in clinical neuropsychological practice, teaching, research, and community service. In addition to COVID-19, his research interests focus primarily on performance validity tests and personality assessment measures in neuropsychological assessment. He is an Associate Editor for The Clinical Neuropsychologist. He is currently President of the Association of Postdoctoral Programs in Clinical Neuropsychology (APPCN) and is a member of the Steering Committee for the Minnesota Update Conference, which will focus on revising the Houston Conference neuropsychology training guidelines.
- Participants will be able to describe common cognitive and emotional short term outcomes of severe Covid patients.
- Participants will be able to describe common cognitive and emotional long term outcomes of Long Covid patients (aka. Post Acute Sequelae of COVID-19; PASC).
Student Members: FREE!
Professional Members: $20, which includes attendance & 1 CE credit*
Non-members: $40, which includes attendance & 1 CE credit*
*New York Neuropsychology Group is recognized by the New York State Education Department's State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0107
*New York Neuropsychology Group is approved by the American Psychological Association to sponsor continuing education for psychologists. NYNG maintains responsibility for this program and its content.
*Refund Policy: Full refund will be provided if cancellation occurs up to 24 hours prior to the event. Cancellation requests made within 24 hours are non-refundable.
Taquet, M., Geddes, J.R., Husain, M., Luciano, S., & Harrison, P.J. (2021). 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: A retrospective cohort study using electronic health records. Published online on April 6, 2021 in Lancet Psychiatry.
Whiteside, D.M., Basso, M.R., Naini, S.M., Waldron, E., Holker, E., Porter, J., Melnik, T., Niskanen, N., & Tayor, S. (2022a). Outcomes in Post-Acute Sequelae of COVID-19 (PASC) at 6 Months Post-Infection Part 1: Cognitive Functioning. Published online in The Clinical Neuropsychologist on February 8, 2022.
Whiteside, D.M., Naini, S.M., Basso, M.R., Waldron, E., Holker, E., Porter, J., Niskanen, N., Melnik, T., & Tayor, S. (2022b). Outcomes in Post-Acute Sequelae of COVID-19 (PASC) at 6 Months Post-Infection Part 2: Psychological Functioning. Published online in The Clinical Neuropsychologist on January 31, 2022 .